Can culturally tailored programs help black smokers quit for good?

NCT ID NCT07419425

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 5 times

Summary

This study compares three different quit-smoking programs for Black adults who smoke and want to quit. Participants will receive nicotine patches plus either standard quitline calls, more intensive counseling, or intensive counseling with financial incentives. The goal is to see which approach works best for long-term quitting, measured by a saliva test at 26 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nicotine patch
What this could lead to
If successful, this could show that culturally specific, intensive support programs help more Black adults quit smoking for good.
What could go wrong
This trial hasn't started yet, and results may not apply to all smokers. The intensive programs may not be more effective than standard quitline services.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arizona State University

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85004, United States

  • Indiana University

    NOT_YET_RECRUITING

    Indianapolis, Indiana, 46202, United States

  • UW School of Medicine and Public Health

    RECRUITING

    Milwaukee, Wisconsin, 53233, United States

  • University of Kansas Medical Center Research Institute, Inc

    NOT_YET_RECRUITING

    Kansas City, Kansas, 66160, United States

  • Virginia Commonwealth University

    NOT_YET_RECRUITING

    Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.